Company Valuation: Elliptic Laboratories ASA

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 2,882 2,295 1,786 1,103 714.9 334.8 - -
Change - -20.36% -22.15% -38.24% -35.2% -53.17% - -
Enterprise Value (EV) 1 2,681 2,129 1,697 1,046 671.8 267.8 283.9 291.7
Change - -20.57% -20.32% -38.34% -35.79% -60.15% 6.04% 2.74%
P/E -252x -71.1x -47.3x 116x -5.14x -10.7x -53.7x 56x
PBR 8.41x 7.04x 5.82x 3.39x 3.8x 1.57x 1.58x 1.5x
PEG - -0x -2.9x -1x 0x 0.1x 0.7x -0x
Capitalization / Revenue 45.7x 44.1x 26.1x 8.36x 6.96x 3.28x 2.76x 2.21x
EV / Revenue 42.5x 40.9x 24.8x 7.93x 6.54x 2.62x 2.34x 1.93x
EV / EBITDA -948x -69.1x -50.6x 41.7x -32.5x -45.3x 16.2x 8.07x
EV / EBIT -241x -50.5x -34.1x 222x -14.8x -8.5x -32.3x 36.7x
EV / FCF -94.3x -59x - - -29.1x -10.7x -28.4x -292x
FCF Yield -1.06% -1.69% - - -3.44% -9.34% -3.52% -0.34%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.11 -0.31 -0.36 0.09 -1.32 -0.2475 -0.0494 0.0473
Distribution rate - - - - - - - -
Net sales 1 63.04 52.06 68.32 131.9 102.7 102.2 121.3 151.3
EBITDA 1 -2.829 -30.81 -33.52 25.12 -20.68 -5.917 17.56 36.17
EBIT 1 -11.14 -42.13 -49.74 4.71 -45.44 -31.5 -8.792 7.947
Net income 1 -11.16 -32.04 -37.85 8.96 -139 -32.05 -6.465 6.262
Net Debt 1 -201 -165.5 -89.72 -57.04 -43.06 -67.03 -50.86 -43.07
Reference price 2 27.750 22.050 17.040 10.480 6.790 2.650 2.650 2.650
Nbr of stocks (in thousands) 103,842 104,074 104,838 105,275 105,287 126,337 - -
Announcement Date 10/03/22 17/02/23 15/02/24 27/02/25 26/02/26 - - -
1NOK in Million2NOK
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-10.71x2.62x-45.26x-.--% 34.62M
-346.15x6.52x24.36x-.--% 23.96B
154.12x0.86x10.85x-.--% 7.4B
15.12x - - - 4.65B
59.62x1.48x10.63x-.--% 3.46B
21.9x - - - 439M
-11.09x - - - 377M
Average -16.74x 2.87x 0.15x 0% 5.76B
Weighted average by Cap. -170.39x 4.81x 20.06x 0%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. ELABS Stock
  4. Valuation Elliptic Laboratories ASA